Viral Genetics Inc. Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.
SAN MARINO, Calif.--(BUSINESS WIRE)--Biotechnology company Viral Genetics (Other OTC:VRAL) is pursuing a promising new therapy for Lyme Disease with a $116,000 grant from Time for Lyme, Inc.